3,511 results found

The Canadian Nutrient File (CNF) is a food composition database maintained by the federal government.

The OCP has released proposed revisions to Ontario Regulation 58/11 under the DPRA and is seeking feedback on the changes.

The SFOA was intended to replace both the Smoke-Free Ontario Act and the Electronic Cigarettes Act, 2015 with a single legislative framework.

The regulation of private label drug products remains in flux with the recent decision of the Ontario Superior Court of Justice (Divisional Court) and potential appeal of that decision.

The Ontario Ministry of Health and Long-Term Care announced, on May 20, 2015, changes to generic drug pricing that are retroactive to April 1, 2013.

Queen's Park resumes today after summer break, with much to keep them busy this fall. They will focus on the labour law changes and marijuana legalization which is set for July of next year.

Kathleen Wynne announced that 150 stores will sell marijuana once it is legalized and the LCBO will oversee the operation of all stores.

Everyone knew that the marketing and promotion restrictions on packaging for licensed producers in the recreational market were going to be onerous.

The pan-Canadian Pharmaceutical Alliance (pCPA) and the Canadian Generic Pharmaceutical Association (CGPA) have agreed to a new three-year pricing initiative for generic drugs, effective October 1, 2023.

The pan-Canadian Pharmaceutical Alliance (pCPA) recently announced it is formalizing and introducing revisions to the Targeted Negotiation Process (TNP).

Today, the Supreme Court of Canada denied leave to Apotex Inc. and the Canadian Generic Pharmaceutical Association, refusing to hear an appeal that would question the validity of the data protection regulations (section C.08.004.1 of Canada's Food and Drug Regulations).

On March 19, 2018, Health Canada unveiled its proposed regulations under the Cannabis Act applicable to the packaging and labelling of recreational cannabis ...

The Patented Medicine Prices Review Board (PMPRB) recently published its Meds Pipeline Monitor 2022 report, which highlights medicines in the pipeline that may impact future clinical...

The Discussion Paper hints that the PMPRB may propose a number of reforms to the Guidelines which would likely lower the maximum allowable prices of many patented medicines at and after introduction.

On September, 27, 2018, Bill-36 (the Cannabis Statute Law Amendment Act, 2018) was introduced by the Ontario government. If passed, it will, inter alia, enact the Cannabis License Act...

This video is the first in a series of four which will explain the legal framework of the health care system, and regulation of drugs and drug pricing, in Canada at the federal and provincial levels.

In Sobeys West Inc v. Alberta College of Pharmacists, 2016 ABQB 232, the Alberta Court of Queen's Bench held that amendments to the College of Pharmacists' Codes of Ethics and Standards of Practice prohibiting inducements to customers for the purchase of drugs